ARK™ Apixaban Assay - The ARK™ Apixaban Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of apixaban in 3.2% citrated human plasma on automated clinical chemistry analyzers. Apixaban concentrations can be used as an aid in management of patients on apixaban therapy in the following situations where measurement of apixaban levels could be useful to have as additional information: patients at risk for major bleeding, patient experiencing a bleeding episode. The assay is not a stand-alone test and the results should be used in conjunction with other clinical and laboratory findings. For use in adult population.
ARK™ Apixaban Control - The ARK™ Apixaban Control is an assayed quality control material intended for use in quality control of the ARK Apixaban Assay.
ARK™ Ketamine II Assay - The ARK Ketamine II Assay is an immunoassay intended for the qualitative detection and/or semi-quantitative estimation of ketamine in human urine at cutoffs of 50 ng/mL and 100 ng/mL.
ARK™ Ketamine II Assay - The ARK Ketamine II Assay is an immunoassay intended for the qualitative detection and/or semi-quantitative estimation of ketamine in human urine at cutoffs of 50 ng/mL and 100 ng/mL.
ARK™ Ketamine II Assay - The ARK Ketamine II Assay is an immunoassay intended for the qualitative detection and/or semi-quantitative estimation of ketamine in human urine at cutoffs of 50 ng/mL and 100 ng/mL.
ark-tdm.com